- Title
- Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysis
- Creators
- Abubakar Tauseef - Creighton UniversityMaryam Zafar - Creighton UniversityPeter Silberstein - Creighton University, Omaha, Nebraska Dow University of Health Sciences, Karachi, CHI Health, Omaha, Nebraska University of Nebraska Medical Center, Omaha, NebraskaJoseph Nahas - Creighton University, Omaha, Nebraska Dow University of Health Sciences, Karachi, CHI Health, Omaha, Nebraska University of Nebraska Medical Center, Omaha, NebraskaThomas Frederickson - Creighton University, Omaha, Nebraska Dow University of Health Sciences, Karachi, CHI Health, Omaha, Nebraska University of Nebraska Medical Center, Omaha, NebraskaSean Hansen - Creighton University, Omaha, Nebraska Dow University of Health Sciences, Karachi, CHI Health, Omaha, Nebraska University of Nebraska Medical Center, Omaha, NebraskaAnum Abbas - Creighton University, Omaha, Nebraska Dow University of Health Sciences, Karachi, CHI Health, Omaha, Nebraska University of Nebraska Medical Center, Omaha, NebraskaYaman Alali - Creighton UniversityAvdesh Buragadda - Creighton University, Omaha, Nebraska Dow University of Health Sciences, Karachi, CHI Health, Omaha, Nebraska University of Nebraska Medical Center, Omaha, NebraskaOmar K. Abughanimeh - Creighton University, Omaha, Nebraska Dow University of Health Sciences, Karachi, CHI Health, Omaha, Nebraska University of Nebraska Medical Center, Omaha, NebraskaSunil Nair - Creighton UniversityJoseph Thirumalareddy - Creighton University, Omaha, Nebraska Dow University of Health Sciences, Karachi, CHI Health, Omaha, Nebraska University of Nebraska Medical Center, Omaha, NebraskaMohsin Mirza - Creighton University
- Publication Details
- Federal practitioner, Vol.39(Suppl 3), pp.S72-S80
- Publisher
- Frontline Medical Communications Inc
- Identifiers
- 991005966260702656
- Academic Unit
- Hematology & Oncology; Hospital Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysis
Federal practitioner, Vol.39(Suppl 3), pp.S72-S80
08/01/2022
Metrics
5 Record Views